Appointment of Justin James as CEO of Vitura Health Limited
Vitura Health Limited (ASX: VIT) is excited to announce the appointment of Justin James as the new Chief Executive Officer, effective June 1, 2026. Mr. James brings a wealth of experience in healthcare, regulatory affairs, governance, and business transformation, underpinned by a strong history of driving financial success. Previously serving as the CEO of Health Insurance Fund of Australia (HIF), Mr. James led the organization through a major financial transformation, overseeing a revenue range of AU$150 to AU$180 million. His leadership resulted in a significant improvement in financial performance, with annual net profits reaching AU$5 to AU$20 million.
Mr. James also has extensive experience in emerging therapies, including medicinal cannabis and psychedelic-assisted treatments, aligning well with Vitura’s strategic focus. His solid governance background is evident in his current roles with key healthcare organizations. Vitura’s board eagerly anticipates Mr. James' leadership in steering the company towards its next phase of growth.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Appointment of Justin James as CEO of Vitura Health Limited
Vitura Health Limited (ASX: VIT) is excited to announce the appointment of Justin James as the new Chief Executive Officer, effective June 1, 2026. Mr. James brings a wealth of experience in healthcare, regulatory affairs, governance, and business transformation, underpinned by a strong history of driving financial success. Previously serving as the CEO of Health Insurance Fund of Australia (HIF), Mr. James led the organization through a major financial transformation, overseeing a revenue range of AU$150 to AU$180 million. His leadership resulted in a significant improvement in financial performance, with annual net profits reaching AU$5 to AU$20 million.
Mr. James also has extensive experience in emerging therapies, including medicinal cannabis and psychedelic-assisted treatments, aligning well with Vitura’s strategic focus. His solid governance background is evident in his current roles with key healthcare organizations. Vitura’s board eagerly anticipates Mr. James' leadership in steering the company towards its next phase of growth.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au